Biolife Solutions (BLFS) Share-based Compensation (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Share-based Compensation of $4.8 million for Q1 2026, up 15.72% year-over-year from $4.2 million in Q1 2025, and down 32.09% quarter-over-quarter from $7.1 million in Q4 2025.
Biolife Solutions (BLFS) Share-based Compensation (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Share-based Compensation for 17 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 15.72% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $23.6 million (down 18.16% YoY), while the FY2025 annual figure was $23.0 million, down 25.64% from the prior year.
- Share-based Compensation fell to $4.8 million in Q1 2026 per BLFS's latest filing, from $7.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $52.4 million in Q3 2022 and bottomed at $1.2 million in Q2 2022.
- Historically, Share-based Compensation has averaged $9.3 million across 5 years, with a median of $6.9 million in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 1064.44% — and 2023, when it sank 82.6%.
- Biolife Solutions' Share-based Compensation stood at $7.7 million in 2022, then climbed by 29.3% to $9.9 million in 2023, then increased by 7.91% to $10.7 million in 2024, then tumbled by 33.81% to $7.1 million in 2025, then slumped by 32.09% to $4.8 million in 2026.
- Business Quant data shows BLFS's Share-based Compensation at $4.8 million in Q1 2026, $7.1 million in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 3.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.07 Mn |
| Jun 30, 2026 | 3.07 Mn |
| Mar 31, 2026 | 4.81 Mn |
| Mar 31, 2026 | 4.81 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | 10.69 Mn |
| Dec 31, 2024 | 10.69 Mn |
| Sep 30, 2024 | 5.33 Mn |
| Sep 30, 2024 | 5.33 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.18 Mn |